Prof. Fabrizio Piazza, PhD

Explore latest insights on ARIA and CAA in AAT, focusing on: Antibody-driven amplification of CAA-related inflammation (CAA-ri) The ARIA Paradox Emerging Biomarkers reshaping the pathophysiological interpretation of ARIA Therapeutic opportunities Safety monitoring strategies

#mdpijcm #2025ReviewPaper Clinical and #Neuroradiological_Manifestations of #Cerebra_Amyloid_Angiopathy 🎯mdpi.com/3208782 ✍️@MlzZedde @Prof_Piazza @MediPharma_MDPI #small_vessel_disease; CAA-related #inflammation

The VCID Clinical Trials work group of the Vascular Cognitive Disorders PIA's The Basics webinar is set for March 10. Registration link:  alz-org.zoom.us/webinar/regist… Become a member of ISTAART Vascular PIA and be part of the new activities we are planning! istaart.alz.org/groups/home/74

𝗜𝘀 𝗔𝗥𝗜𝗔 𝗮𝗻 𝗮𝗱𝘃𝗲𝗿𝘀𝗲 𝗲𝘃𝗲𝗻𝘁 𝗼𝗳 𝗔𝗔𝗧 𝗶𝗻 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝗱𝗶𝘀𝗲𝗮𝘀𝗲, 𝗼𝗿 𝘁𝗵𝗲 𝗶𝗮𝘁𝗿𝗼𝗴𝗲𝗻𝗶𝗰𝗮𝗹𝗹𝘆 𝗶𝗻𝗱𝘂𝗰𝗲𝗱 𝗺𝗮𝗻𝗶𝗳𝗲𝘀𝘁𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗖𝗔𝗔-𝗿𝗶? mdpi.com/2218-273X/16/1…

#Microbiota-gut-brain axis dysregulation in #Alzheimer’s disease and its modulation through #probiotic supplementation Fresh new published, congrats to Moira Marizzoni and many thanks to Prof. Annamaria Cattaneo and team! @iCABNetwork @alzassociation sciencedirect.com/science/articl…

#Cerebrospinal Fluid #Biomarkers Profiling in Cerebral #Amyloid Angiopathy and Relationship With Disease Phenotypes Congrats, Mattia Losa, it has been a pleasure working with you and the whole team! @iCABNetwork @alzassociation #mnesys @unimib ahajournals.org/doi/10.1161/JA…

#Donanemab receives positive opinion from the European Medicine Agency Committee for Medicinal Products for Human Use (CHMP) in early symptomatic #Alzheimers disease. investor.lilly.com/news-releases/…

Cracking the code of cerebral amyloid angiopathy in AD. - Neuropathology of CAA and Its Comorbidity with AD (Prof. Jaunmuktane Z) - Rethinking ARIA in Alzheimer’s Immunotherapy: Iatrogenic CAA-ri. (Prof. Piazza F) online. Jun 13, 2025 at 4:30pm (CEST) #form" target="_blank" rel="nofollow noopener">aceglobalresearchsummit.com/?mc_cid=62e60c…

#Hemostasis components in cerebral #amyloid angiopathy and #Alzheimer disease Contribution of hemostasis components to Aβ deposition, endothelial and BBB dysfunction, vessel fragility, cerebral bleeding, and cognitive changes. link.springer.com/article/10.100… #donanemab #lecanemab

Comment by #European #AlzheimersDisease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of #donanemab for early Alzheimer’ s disease sciencedirect.com/science/articl… @EMA_News @alzassociation #VascularPIA @unimib

sciencedirect.com/science/articl… @EliLillyItalia @unimib @alzassociation @SINdem_Ass

#lecanemab #donanemab @eisaiusneuro @biogen @EliLillyItalia @SINdem_Ass karger.com/ndd/article/do…

Anti-amyloid treatments, a therapeutic revolution, ready for Europe karger.com/ndd/article/do…

Clinical and Neuroradiological Manifestations of Cerebral Amyloid Angiopathy: A Closer Look into the Natural History of a Frequent Disease mdpi.com/3208782 #mdpijcm

Traumatic Brain Injury and Chronic Traumatic Encephalopathy: Not Only Trigger for Neurodegeneration but Also for Cerebral Amyloid Angiopathy? mdpi.com/3257070 #mdpibiomedicines

Positron Emission Tomography in Cerebral Amyloid Angiopathy: A Scoping Review mdpi.com/3255760 #mdpiapplsci via @Applsci

Clinical and Neuroradiological Manifestations of Cerebral Amyloid Angiopathy: A Closer Look into the Natural History of a Frequent Disease mdpi.com/3208782 #mdpijcm